Articles about Fred Hutchinson Cancer Research Center – Page 2 of 5

Fred Hutch study: Here’s what it would take to reopen schools safely during the pandemic

New research led by Seattle’s Fred Hutchinson Cancer Research Center outlines the steps needed to safely reopen schools during the… Read More

Super spreaders drive COVID-19: 80% of those infected likely don’t spread disease, Fred Hutch study finds

About 80% of people infected with the novel coronavirus don’t spread the infection to anyone else, leaving the so-called super… Read More

Fred Hutchinson Cancer Research Center cuts 76 jobs, eliminates 81 open roles, citing downturn

Updated with Fred Hutch confirmation and additional details. Seattle’s Fred Hutchinson Cancer Research Center is cutting more than 70 jobs,… Read More

Fred Hutchinson Cancer Research Center names new board chair and adds trustees

The Fred Hutchinson Cancer Research Center named a new chair of its board of trustees, Kathy Surace-Smith, a senior vice… Read More

Researchers want to pick up the pace on early testing and treatment for COVID-19

Scientists from Seattle’s Fred Hutchinson Cancer Research Center and the University of Washington say the search for COVID-19 treatments should… Read More

Amid COVID-19 pandemic, experts lay out 10-point plan for a genomic revolution in public health

From the early days of the coronavirus pandemic, genetic sleuths have been at the forefront in the global effort to… Read More

Fred Hutch’s president says a new strain of virus research center is needed to fight future outbreaks

Seattle’s Fred Hutchinson Cancer Research Center already has dozens of scientists working on infectious diseases, including COVID-19 — but the… Read More

Bank of America gives $500,000 to Fred Hutch and Seattle Cancer Care Alliance for COVID-19 relief

Seattle’s Fred Hutchinson Cancer Research Center and its clinical-care partner, Seattle Cancer Care Alliance, are receiving a $500,000 grant from… Read More

Disease experts say it’s time to join forces to make coronavirus vaccines

Unprecedented collaborations involving the biotech industry and government agencies are urgently needed to develop and produce the billions of doses… Read More

Risky business: Scientists seek volunteers for ‘CovidWatch’ virus-tracking study

Are you at risk of getting COVID-19? You may be just the kind of person researchers at Seattle’s Fred Hutchinson… Read More

Seattle researchers report early results from first US ‘swab and send’ COVID-19 surveillance program

Updated below with details from news conference. Early results from a first-of-its-kind at-home testing program for COVID-19, analyzing more than… Read More

Taken out of the ball game, coaches go online to teach skills and aid Fred Hutch’s COVID-19 fight

Tanner Swanson was a week away from starting his first full season in the Major Leagues as a member of… Read More

Infectious disease expert Steve Pergam shares his prescription for a safe weekend get-together

Need to get out of the house this weekend? Steve Pergam, an epidemiologist at Seattle’s Fred Hutchinson Cancer Research Center,… Read More

Study says travel restrictions can delay, but can’t defeat a global coronavirus outbreak

Comparisons of the real-world spread of the COV-19 coronavirus with computer models indicate that the travel restrictions imposed by authorities… Read More

A protein found in scorpion venom just might help take the sting out of arthritis

Scientists at Seattle’s Fred Hutchinson Cancer Research Center have identified a mini-protein in scorpion venom that can target joint inflammation… Read More

Genetic analysis suggests coronavirus infections double every six days, spreading to hundreds

Update for 5:50 p.m. PT May 28: An updated analysis proposes a different scenario for the origins of the U.S.… Read More

Vote for Health Innovation of the Year: Tech and life sciences unite at the 2020 GeekWire Awards

Editor’s note: The GeekWire Awards are now virtual on July 23. Watch live below. Technology is increasingly influencing the science… Read More

Podcast

Interview: New Fred Hutch president on the fight against cancer, and the tech industry’s central role

Dr. Thomas Lynch is in his first week as the new leader of the Fred Hutchinson Cancer Research Center, but… Read More

Researchers halt ‘ineffective’ HIV vaccine trial led by Fred Hutch with Gates Foundation backing

A three-year-long clinical trial of an HIV vaccine in South Africa, funded in part by the Bill & Melinda Gates… Read More

Geek of the Week: Fred Hutch’s Jeanne Chowning committed to diversity and inclusion in science

Dr. Jeanne Ting Chowning is a lifelong educator with a passion for science — and a commitment to making sure… Read More

Podcast

Scientists pursue new genetic insights for health: Inside the world of ‘deep mutational scanning’

It has been nearly two decades since scientists accomplished the first complete sequencing of the human genome. This historic moment… Read More

Scientists link mysterious snippets of DNA to cell growth and tumor suppression

Why do some strings of genetic code remain virtually unchanged despite tens of millions of years of evolutionary divergence? A… Read More

Fred Hutch names Thomas Lynch new president: ‘We’re going to make remarkable leaps’

Seattle’s Fred Hutchinson Cancer Research Center has found its next leader, announcing Tuesday that Dr. Thomas J. Lynch Jr. will… Read More

Barbie puts on a lab coat and finds formula to win holiday diorama contest at Seattle’s Fred Hutch

We’ve seen Barbie ride a horse, or cruise the beach in a dune buggy. It’s cool to see that she… Read More

Thin metal films loaded with immune cells show promise as cancer therapy

Researchers at Seattle’s Fred Hutchinson Cancer Research Center have demonstrated the effectiveness of a new method for getting immune cells… Read More

Fred Hutch loses data chief in latest leadership shakeup for Seattle cancer research powerhouse

— Matthew Trunnell is stepping down from his post as chief data officer at the Fred Hutchinson Cancer Research Center.… Read More

Adaptive Biotechnologies beats estimates with Q3 revenue of $26.1M as shares rise 6%

Adaptive Biotechnologies‘ stock rose 6 percent to $30 per share in after-hours trading on Tuesday after the company reported higher… Read More

Gene found in embryos can cloak cancer from common immunotherapy methods, researchers find

The question of why immunotherapy eradicates cancer in some people while having little effect on the majority of patients has… Read More

Podcast

Why this cancer researcher (and survivor) is climbing Kilimanjaro to raise money to study cancer

Kristin Anderson has already fought cancer in more ways than one. She’s a cancer survivor whose battle with breast cancer… Read More

Adaptive Biotechnologies co-founder leaves Fred Hutch; IPO filing warned of IP risks from dual roles

Dr. Harlan Robins, co-founder and chief scientific officer of Seattle-based Adaptive Biotechnologies, stepped down from his role as head of… Read More